WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (NASDAQ: NURO), a medical device company focused on the development and sale of proprietary products used to diagnose neuropathies and neurovascular disorders, announced today that it is scheduled to present at SIGnificant Investment Options in Healthcare of Susquehanna Financial Group, LLLP at The Omni Berkshire Place in New York City at 8:30am (EST) on Thursday, March 1, 2007. The audio presentation will be simultaneously available via webcast on the “Investors” home page at http://www.neurometrix.com.
